PARLIAMENTARY WRITTEN QUESTION
Coronavirus: Vaccination (18 July 2023)

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 27 June 2023 to Question 190812 on Coronavirus: Vaccination, what assessment he has made of (a) the robustness and (b) the implications for his policies of the study's findings in Table 2 on levels of Serious Adverse Events for people vaccinated with the Pfizer mRNA vaccine.

Asked by:
Esther McVey (Conservative)

All COVID-19 vaccines deployed in the United Kingdom have been authorised for use following a rigorous review by the independent regulator, the Medicines and Healthcare products Regulatory Agency (MHRA).

The MHRA continuously monitors safety during the widespread use of a vaccine. It keeps all available evidence under review, including studies, published literature and data arising from usage in the UK and internationally, including the article referenced. The MHRA communicates safety advice based upon the totality of evidence rather than the strengths and limitations of individual data sources.

Answered by:
Maria Caulfield (Conservative)
24 July 2023